https://www.prnewswire.com/news-releases/european-commission-approves-csls-andembry-garadacimab-for-the-prevention-of-recurrent-attacks-of-hereditary-angioedema-hae-302375479.html
- Forums
- ASX - By Stock
- Andembry(garadacimab) approved in Europe
CSL
csl limited
Add to My Watchlist
0.04%
!
$269.70

https://www.prnewswire.com/news-releases/european-commission-appr...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$269.70 |
Change
0.100(0.04%) |
Mkt cap ! $130.5B |
Open | High | Low | Value | Volume |
$269.60 | $270.44 | $268.40 | $40.08M | 148.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10 | $269.69 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$269.73 | 59 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 43 | 269.470 |
3 | 16 | 269.460 |
3 | 31 | 269.440 |
1 | 1 | 269.430 |
1 | 34 | 269.420 |
Price($) | Vol. | No. |
---|---|---|
269.530 | 9 | 2 |
269.540 | 6 | 1 |
269.550 | 3 | 1 |
269.560 | 25 | 1 |
269.570 | 5 | 1 |
Last trade - 12.04pm 07/08/2025 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |